As a consequence, miR-23a overexpression in AML cells will most likely induce specific deregulation of gene expression profiles, which will not only include the down-regulation of TOP2B but also the up- and/or downregulation of many other genes. The gene discussed is TOP2B; the disease is acute myeloid leukemia.